Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flowers

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Blood|March 7, 2009
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren, Ethel S Gilbert, J Douglas Rizzo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantationRyan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.
Bone Marrow Transplantation|September 27, 2020
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approachMasumi Ueda Oshima, Brenda M Sandmaier, Effie Petersdorf, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host DiseaseMarie Bleakley, Alison Sehgal, Stuart Seropian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Blood|May 10, 2007
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersChunkang Chang, Barry E Storer, Bart L Scott, et al.
Placenta|March 27, 2024
High-throughput mRNA sequencing of human placenta shows sex differences across gestationAmy E Flowers, Tania L Gonzalez, Yizhou Wang, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Blood|March 7, 2009
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren, Ethel S Gilbert, J Douglas Rizzo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantationRyan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.
Bone Marrow Transplantation|September 27, 2020
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approachMasumi Ueda Oshima, Brenda M Sandmaier, Effie Petersdorf, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host DiseaseMarie Bleakley, Alison Sehgal, Stuart Seropian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Blood|May 10, 2007
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersChunkang Chang, Barry E Storer, Bart L Scott, et al.
Placenta|March 27, 2024
High-throughput mRNA sequencing of human placenta shows sex differences across gestationAmy E Flowers, Tania L Gonzalez, Yizhou Wang, et al.
Pageof 21